Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding

BACKGROUND: The outbreak of coronavirus (SARS-CoV-2) disease caused more than 100,000,000 people get infected and over 2,200,000 people being killed worldwide. However, the current developed vaccines or drugs may be not effective in preventing the pandemic of COVID-19 due to the mutations of coronav...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Li Jun, Chen, Rui Hong, Hamdoun, Sami, Coghi, Paolo, Ng, Jerome P.L., Zhang, David Wei, Guo, Xiaoling, Xia, Chenglai, Law, Betty Yuen Kwan, Wong, Vincent Kam Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier GmbH. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098048/
https://www.ncbi.nlm.nih.gov/pubmed/34029937
http://dx.doi.org/10.1016/j.phymed.2021.153591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098048/
https://www.ncbi.nlm.nih.gov/pubmed/34029937
http://dx.doi.org/10.1016/j.phymed.2021.153591

Ejemplares similares